Recombinant ACE2-Ig Fusion Protein Neutralizes SARS-CoV-2

다국어 초록 (Multilingual Abstract)

A novel coronavirus (SARS-CoV-2) is the causative agent for the COVID-19 pandemic, and needs for effective antiviral drugs have been demanded. Angiotensin-converting enzyme 2 (ACE2) has been shown to be a cellular receptor for SARS-CoV and SARS-CoV-2. For the therapeutic validation of ACE2, a recombinant protein consisting of the ACE2 extracellular domain fused to the IgG1 Fc domain (ACE2-Ig) was generated. ACE2-Ig exhibits proper pharmacological properties and binds with a high affinity to SARS-CoV and SARS-CoV-2 receptor-binding domain. Further, it neutralizes virus with SARS-CoV and SARS-CoV-2 spike proteins. Taken overall, these data suggest that ACE2-Ig has substantial anti-SARS-CoV-2 properties and warrant further study concerning its potential applications for the treatment of SARS-CoV-2.ㅍㅍㅍㅍㅍㅍ

다국어 초록 (Multilingual Abstract)

A novel coronavirus (SARS-CoV-2) is the causative agent for the COVID-19 pandemic, and needs for effective antiviral drugs have been demanded. Angiotensin-converting enzyme 2 (ACE2) has been shown to be a cellular receptor for SARS-CoV and SARS-CoV-2. For the therapeutic validation of ACE2, a recombinant protein consisting of the ACE2 extracellular domain fused to the IgG1 Fc domain (ACE2-Ig) was generated. ACE2-Ig exhibits proper pharmacological properties and binds with a high affinity to SARS-CoV and SARS-CoV-2 receptor-binding domain. Further, it neutralizes virus with SARS-CoV and SARS-CoV-2 spike proteins. Taken overall, these data suggest that ACE2-Ig has substantial anti-SARS-CoV-2 properties and warrant further study concerning its potential applications for the treatment of SARS-CoV-2.

참고문헌 (Reference)

1 Yan R, "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2" 367 : 1444-1448, 2020

2 Liu P, "Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation" 94 : 114-125, 2018

3 Lei C, "Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig" 11 : 2070-, 2020

4 Jackson CB, "Mechanisms of SARS-CoV-2 entry into cells" 23 : 3-20, 2022

5 Junker F, "Fc gamma receptors and their role in antigen uptake, presentation, and T cell activation" 11 : 1393-, 2020

6 Wrapp D, "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation" 367 : 1260-1263, 2020

7 Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" 395 : 497-506, 2020

8 Rice GI, "Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study" 48 : 914-920, 2006